TrialCritical care medicine2016

Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial.

Bita Shakoory et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.